AGEX THERAPEUTICS
AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprie... tary induced Tissue Regeneration (iTR™) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte™ technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology.
AGEX THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
Alameda, California, United States
Country:
United States
Website Url:
http://www.agexinc.com
Total Employee:
101+
Status:
Active
Contact:
(510)871-4190
Email Addresses:
[email protected]
Total Funding:
63.79 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Juvenescence
Juvenescence investment in Private Equity Round - AgeX Therapeutics
Juvenescence
Juvenescence investment in Private Equity Round - AgeX Therapeutics
KIZOO Technology Capital
KIZOO Technology Capital investment in Venture Round - AgeX Therapeutics
Jim Mellon
Jim Mellon investment in Venture Round - AgeX Therapeutics
John Mauldin
John Mauldin investment in Venture Round - AgeX Therapeutics
IBS Capital
IBS Capital investment in Venture Round - AgeX Therapeutics
Lineage Cell Therapeutics
Lineage Cell Therapeutics investment in Venture Round - AgeX Therapeutics
Alfred Kingsley
Alfred Kingsley investment in Venture Round - AgeX Therapeutics
Official Site Inspections
http://www.agexinc.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.03 K
- Host name: 12.60.154.104.bc.googleusercontent.com
- IP address: 104.154.60.12
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
